Recently, tremendous progress has been made in developing selective and effective PI3K-targeted therapies for the treatment of cancer and other immune/inflammatory diseases on the basis of a vast amount of studies on the roles of specific PI3K isoforms and fine-tuned modulators of PI3Ks in a particular disease context. Here, PIK3CD is linked to cancer.